期刊文献+

原发性卵巢癌p15 mRNA及其蛋白的表达

EXPRESSION OF p15 mRNA AND PROTEIN IN PRIMARY OVARIAN CARCINOMAS
下载PDF
导出
摘要 ①目的 检测原发性卵巢癌中p15mRNA及其蛋白的表达 ,以探讨该基因在原发性卵巢癌发生发展过程中的作用。②方法 应用逆转录 聚合酶链反应 (RT PCR)以及免疫组化方法 ,对 4 8例原发性卵巢癌以及 15例正常卵巢组织中 p15mRNA及其蛋白的表达进行检测。 ③结果 原发性卵巢癌中 p15mRNA及其蛋白的表达与正常卵巢组织比较差异有显著性 (χ2 =4 .16、5 .11,P <0 .0 5 )。p15mRNA及其蛋白表达与卵巢癌组织学类型相关 (χ2 =5 .5 9、7.30 ,P <0 .0 5 ) ,与其FIGO分期及组织学分级无关 (χ2 =1.13~ 2 .0 9,P >0 .0 5 )。④结论 原发性卵巢癌中p15mRNA及其蛋白表达异常 ,提示该基因的失活与原发性卵巢癌的发生有关。 Objective To study the expression of p15 mRNA and protein in primary ovarian carcinoma, and to define the role of p15 gene in the generation and development of the disease. Methods By using reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry assays, expressions of p15 mRNA and protein were detected in 48 primary ovarian carcinomas and 15 normal ovarian tissues. Results Significant differences existed in the expression of p15 mRNA and protein between the two groups(χ 2=4.16,5.11;P<0.05). The expressions of p15 mRNA and protein correlated with the histological types (χ 2=5.59,7.30;P<0.05), but not with FIGO stage and histological grade(χ 2=1.13-2.09,P>0.05). Conclusion In primary ovarian carcinoma, the expressions of p15 mRNA and its protein are abnormal, which suggestive of that inactivation of p15 gene is associated with oncogenesis
出处 《齐鲁医学杂志》 2004年第4期291-293,共3页 Medical Journal of Qilu
关键词 卵巢肿瘤 基因 P15 蛋白质P15 基因表达 免疫组织化学 ovarian neoplasms gene, p15 protein P15 gene expressions immunohistochemistry
  • 相关文献

参考文献9

  • 1Hannon GJ, Beach D. p15INK4B is a potential effector of TGF-β induced cell cycle arrest [J]. Nature (Lond), 1994, 371: 257.
  • 2Jen J, Harper WJ, Bigner SH, et al. Deletion of p16 and p15 genes in brain tumors [J]. Cancer Res, 1994, 54: 6353.
  • 3Fuqua SAW, Falette NF, McGuire WL. Sensitive detection of estrogen receptor RNA by polymerase chain reaction assay [J]. J Natl Cancer Inst, 1990, 82: 858.
  • 4Stone S, Dayananth P, Jiang P, et al. Genomic structure, expression and mutational analysis of the p15 (MTS2) gene [J]. Oncogene, 1995, 11: 987.
  • 5Herman JG, Merlo A, Mao L, et al. Inactivation of CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancer [J]. Cancer Res,1995, 55: 4525.
  • 6Herman JG, Latif F, Weng Y, et al. Sliencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma [J]. Proc Natl Acad Sci USA, 1994, 91: 9700.
  • 7Ichikawa Y, Yoshida S, Koyama Y, et al. Inactivation of p16/CDKN2 and p15/MTS2 genes in different histological types and clinical stages of primary ovarian tumors [J]. Int J Can-cer, 1996, 69: 466.
  • 8Bell DA, Scully RE. Early de novo ovarian carcinoma: a study of 14 cases [J]. Cancer, 1994, 73: 1859.
  • 9Scully RE, Bell DA, Abu-Jawdeh GM. Update on early ovarian cancer and cancer development in benign ovarian tumors [J]. Ovarian Cancer, 1995, 3: 139.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部